Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Withdrawn 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 63Cisplatin 41Pemetrexed 39Drug Therapy 37anlotinib 23osimertinib 22Etoposide 19tislelizumab 18Paclitaxel 18Radiotherapy 17Surgical Procedures, Operative 16pembrolizumab 15toripalimab 14130-nm albumin-bound paclitaxel 14aflutinib 13Docetaxel 13Bevacizumab 12sintilimab 10Specimen Handling 10Magnetic Resonance Spectroscopy 10durvalumab 9Injections 9cemiplimab 8Radiosurgery 8Platinum 8PM 01183 8Immunotherapy 8atezolizumab 7Platinum Compounds 7Blood Specimen Collection 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Spermine Synthase × Thoracic × Clear all
NCT07234877 2026-06-04

Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Not yet recruiting
158 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡